Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma
NCT02269995 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2018-11-05
Summary
This surveillance's objectives are:
1. Unknown adverse reactions
2. Incidences of adverse drug reaction
3. Factors considered to have effect to safety and effectiveness
Conditions
Interventions
- DEVICE
-
E7040
E7040 of optimal particle size (-300 um, 300-500 um, or 500-700 um to fit in a target vessel, target lesion, or embolized area) as transcatheter study device will be administered .
Sponsors & Collaborators
-
Eisai Co., Ltd.
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-06
- Primary Completion
- 2015-05-14
- Completion
- 2015-12-25
Countries
- Japan
More Related Trials
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN
-
Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
NCT04722120 ·Status: COMPLETED ·Phase: NA
-
Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass
NCT00512512 ·Status: COMPLETED
-
Role of CEUS as a Secondary Diagnostic Modality
NCT04494022 ·Status: UNKNOWN ·Phase: NA
-
Liver Cancer HepaSphere Combined With Cryosurgery
NCT02545556 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver
NCT01501240 ·Status: WITHDRAWN
-
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
NCT01116804 ·Status: COMPLETED ·Phase: PHASE1
-
A Worldwide Score for Hepatocellular Cancer and Liver Transplantation
NCT03595345 ·Status: COMPLETED
-
Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents
NCT01341132 ·Status: UNKNOWN
-
Detect and Expunge Concealed Tumors of the Liver
NCT06141564 ·Status: ACTIVE_NOT_RECRUITING
-
Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits
NCT01937286 ·Status: COMPLETED
-
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease
NCT02658786 ·Status: WITHDRAWN
-
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
NCT02074202 ·Status: UNKNOWN ·Phase: PHASE3
-
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
NCT06537193 ·Status: RECRUITING ·Phase: NA
-
PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)
NCT01320852 ·Status: COMPLETED ·Phase: NA
-
New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules
NCT07272083 ·Status: NOT_YET_RECRUITING
-
Circulating Cell-free DNA-based Epigenetic Biomarker MSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis
NCT03311152 ·Status: COMPLETED ·Phase: NA
-
"Double Low-Dose" DECT for HCC Imaging
NCT03045445 ·Status: COMPLETED ·Phase: NA
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions
NCT03652636 ·Status: COMPLETED ·Phase: PHASE4
-
Recurrence of Hepatocellular Carcinoma
NCT01520779 ·Status: COMPLETED
-
Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients
NCT02793791 ·Status: UNKNOWN ·Phase: NA
-
Dual and Single Switching Monopolar RFA Using Separable Clustered Electrode for Treatment of HCC
NCT03699657 ·Status: COMPLETED ·Phase: NA
-
Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
NCT03162198 ·Status: COMPLETED
-
Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
NCT05971108 ·Status: RECRUITING ·Phase: NA